Bernard Fraisse
Source of wealth: Pharmaceuticals
...
...
Modules
Biography
Bernard Fraisse is the CEO of Fareva, one of the world's largest contract pharmaceutical, household and cosmetics companies.
After getting his degree in mechanical engineering, Fraisse worked as a chemical salesman before starting his own business in 1990.
The first year his company generated $4.5 million in revenue. In 2022, Fareva pulled in $2.1 billion in revenue.
He refuses to take any private equity money and intends to keep the company in family hands and independent.
Fareva, headquartered in Luxembourg, has 13,000 employees and 41 locations around the world.
Financial Assets
Financial assets information not available.
The Great Lie of Mega-Fortunes: The Case of Bernard Fraisse
Billionaires are often presented under the romantic myth of the 'self-made person': a narrative designed to justify opulence as the natural reward for hard work, effort, or ingenuity. However, when confronting such extreme volumes of wealth with macroeconomic reality, the meritocracy narrative completely breaks down. No individual can legitimately generate through personal effort a fortune equivalent to millions of times the average working-class salary. Capital at the top does not grow because of exceptional talent; it expands through an implacable dynamic where accumulated money works exponentially faster than people, devouring the wealth generated by productive labor.
The immense fortune of Bernard Fraisse, linked to Healthcare and 'Pharmaceuticals', has not been built in a free-market vacuum, but through rent-seeking, the use of exclusive elite influence, the consolidation of monopoly positions, or inherited wealth. Far from taking real private risks, billionaire empires structurally depend on state support through direct subsidies, infrastructure use, exploitation of R&D, public contracts, and offshore tax engineering. While this wealth is equivalent to the physical weight of 30 tons of pure gold, the rest of the planet suffers from an artificial scarcity of basic resources. The fact that this wealth is enough to fully fund the public health system of DR Congo, a country with more than 105800000 million inhabitants for 1.9 years, proves that unlimited accumulation is not an entrepreneurial achievement, but the hijacking of democratic sovereignty.